KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Amortization of Deferred Charges (2016 - 2023)

Supernus Pharmaceuticals (SUPN) has disclosed Amortization of Deferred Charges for 13 consecutive years, with $532000.0 as the latest value for Q1 2023.

  • Quarterly Amortization of Deferred Charges rose 6.4% to $532000.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $532000.0 through Dec 2023, down 74.16% year-over-year, with the annual reading at $532000.0 for FY2023, 74.81% down from the prior year.
  • Amortization of Deferred Charges for Q1 2023 was $532000.0 at Supernus Pharmaceuticals, roughly flat from $530000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $4.5 million in Q4 2021, with the low at $500000.0 in Q1 2022.
  • Average Amortization of Deferred Charges over 5 years is $3.1 million, with a median of $4.0 million recorded in 2019.
  • The sharpest move saw Amortization of Deferred Charges surged 520.92% in 2019, then crashed 88.37% in 2022.
  • Over 5 years, Amortization of Deferred Charges stood at $4.0 million in 2019, then increased by 4.32% to $4.2 million in 2020, then increased by 7.65% to $4.5 million in 2021, then plummeted by 88.22% to $530000.0 in 2022, then rose by 0.38% to $532000.0 in 2023.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $532000.0, $530000.0, and $529000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.